Rock Springs Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001595725

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2025 · 92 positions · Total reported value $1.60B · Top-10 concentration 36.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 39.8% · 9 new · 28 cut · 8 exited

Active Share (vs S&P 500): 96.8% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.5% · vs SPY -9.6% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.4% · vs SPY -4.5% · Latest Value $1.85B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, Rock Springs Capital Management LP disclosed 92 equity positions with a combined reported value of $1.60B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 36.2% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were ARGX ($96.88M), LLY ($90.82M), MRUS ($55.95M). By sector, the heaviest allocations are Health Care 81.2%, Consumer Discretionary 3.5%. Versus the prior quarter, allocation shifted toward Health Care (+0.6pp) and away from Other (-1.3pp).

Versus the prior quarter, Rock Springs Capital Management LP opened 9 new positions, trimmed 28 and fully exited 8, a turnover rate of 39.8% of positions. The portfolio's overlap with the prior quarter was 80% of names.

The largest new positions opened in Q2 2025 were CAI ($21.21M), OMDA ($16.84M), XBI ($12.58M).

Of the 8 positions fully exited versus the prior quarter, the largest were LEGN ($17.40M), WRBY ($15.22M), NVRO ($4.67M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • CAI CARIS LIFE SCIENCES INC · $21.21M
  • OMDA OMADA HEALTH INC · $16.84M
  • XBI SPDR SERIES TRUST · $12.58M
  • ACLX ARCELLX IN · $12.27M
  • CDTX CIDARA THERAPEUTICS INC · $6.53M
  • COGT COGENT BIOSCIENCES INC · $5.75M
  • TMO THERMO FISHER SCIENTIFIC INC · $4.05M
  • CRL CHARLES RIV LABS INTL INC · $409.67K

Fully Exited (vs previous quarter)

  • LEGN LEGEND BIOTECH CORP · prev qtr: $17.40M
  • WRBY WARBY PARKER INC · prev qtr: $15.22M
  • NVRO NEVRO CORP · prev qtr: $4.67M
  • KMTS KESTRA MED TECHNOLOGIES LTD · prev qtr: $3.61M
  • INZY INOZYME PHARMA INC · prev qtr: $3.14M
  • BEAM BEAM THERAPEUTICS INC · prev qtr: $2.93M
  • SGMT SAGIMET BIOSCIENCES INC · prev qtr: $2.57M
  • BCRX BIOCRYST PHARMACEUTICALS INC · prev qtr: $1.67M

Insider Transactions (Form 4)

Latest Rock Springs Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rock Springs Capital Management LP is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 104 US equity positions with a combined value of $2.05B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-78511 (status: Approved), registered 2013-09-27
  • Regulatory AUM (Form ADV): $2.43B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 104 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 44.0% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 10.1%
  • Average position size: $19.70M

Sector Tilt

  • Health Care 96.8%
  • Industrials 1.1%
  • Consumer Discretionary 1.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 16 new, 35 added, 31 reduced, 12 exited
  • 22 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.2%
Technology 1.0%
Materials 0.0%
Other 13.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 175.75K $96.88M 6.05%
6.05%
Hold
2 116.50K $90.82M 5.68%
5.68%
Add
3 1.06M $55.95M 3.50%
3.50%
Add
4 861.15K $54.42M 3.40%
3.40%
Add
5 525.00K $52.84M 3.30%
3.30%
Add
6 1.39M $50.58M 3.16%
3.16%
Hold
7 1.33M $48.97M 3.06%
3.06%
Add
8 82.00K $44.56M 2.79%
2.79%
Reduce
9 140.30K $42.46M 2.65%
2.65%
Reduce
10 818.21K $41.64M 2.60%
2.60%
Reduce
11 355.00K $38.13M 2.38%
2.38%
Add
12 217.00K $37.45M 2.34%
2.34%
Hold
13 242.50K $37.34M 2.33%
2.33%
Reduce
14 640.53K $34.18M 2.14%
2.14%
Reduce
15 128.50K $32.98M 2.06%
2.06%
Reduce
16 989.75K $32.92M 2.06%
2.06%
Add
17 100.00K $32.61M 2.04%
2.04%
Reduce
18 2.82M $31.76M 1.99%
1.99%
Add
19 871.39K $30.47M 1.91%
1.91%
Reduce
20 572.00K $30.40M 1.90%
1.90%
Add
21 931.68K $29.16M 1.82%
1.82%
Hold
22 1.91M $28.24M 1.76%
1.76%
Reduce
23 794.13K $28.13M 1.76%
1.76%
Add
24 286.75K $25.03M 1.56%
1.56%
Reduce
25 837.30K $23.83M 1.49%
1.49%
Reduce
26 185.50K $23.78M 1.49%
1.49%
Reduce
27 1.14M $23.56M 1.47%
1.47%
Hold
28 130.00K $22.88M 1.43%
1.43%
Hold
29 793.65K $21.21M 1.33%
1.33%
New
30 450.37K $19.65M 1.23%
1.23%
Reduce
31 919.95K $16.84M 1.05%
1.05%
New
32 812.65K $16.54M 1.03%
1.03%
Hold
33 530.40K $16.33M 1.02%
1.02%
Add
34 696.00K $15.79M 0.99%
0.99%
Add
35 50.50K $15.75M 0.98%
0.98%
Reduce
36 373.75K $15.14M 0.95%
0.95%
Add
37 710.00K $15.11M 0.94%
0.94%
Reduce
38 6.55M $15.07M 0.94%
0.94%
Reduce
39 700.00K $15.01M 0.94%
0.94%
Reduce
40 617.40K $14.55M 0.91%
0.91%
Add
41 701.41K $14.07M 0.88%
0.88%
Add
42 107.50K $13.95M 0.87%
0.87%
Add
43 154.53K $12.95M 0.81%
0.81%
Add
44 4.96M $12.90M 0.81%
0.81%
Hold
45 151.75K $12.58M 0.79%
0.79%
New
46 186.31K $12.27M 0.77%
0.77%
New
47 4.47M $12.10M 0.76%
0.76%
Reduce
48 59.00K $11.65M 0.73%
0.73%
Hold
49 1.96M $11.23M 0.70%
0.70%
Add
50 51.03K $11.17M 0.70%
0.70%
Reduce

FAQ

What did Rock Springs Capital Management LP buy in 2025-Q2?

In its 2025-Q2 13F filing, Rock Springs Capital Management LP reported 92 equity positions worth $1.60B in aggregate; its largest disclosed positions were ARGX ($96.88M), LLY ($90.82M), MRUS ($55.95M).

How large is Rock Springs Capital Management LP's portfolio?

Rock Springs Capital Management LP reported $1.60B of long equity holdings across 92 positions as of 2025-Q2. Top-10 holdings account for 36.2% of reported value.

What is Rock Springs Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rock-springs-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →